+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method



Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method



Pharmacology 92(1-2): 99-107



Ten mammalian diacylglycerol kinase (DGK) isozymes (α-κ) have been identified. Recent studies have revealed that DGK isozymes play pivotal roles in a wide variety of pathophysiological functions. Thus, it is important to be able to easily check DGK activity in each pathophysiological event. Moreover, the conventional DGK assay is quite laborious because it requires the use of a radioisotope and thin-layer chromatography including multiple extraction steps. In order to minimize the laborious procedures, we established a non-radioactive, single well, two-step DGK assay system. We demonstrated that, compared to the conventional method, the new assay system has comparable sensitivity and much higher efficiency, and is effective in detecting potential agents with high reliability (Z'-factor = 0.69 ± 0.12; n = 3). Using the newly developed assay, we comprehensively evaluated the DGK isozyme selectivities of commercially available DGK inhibitors, R59022 and R59949, in vitro. We found that among 10 isozymes, R59022 strongly inhibited type I DGKα and moderately attenuated type III DGKε and type V DGKθ, and that R59949 strongly inhibited type I DGK α and γ, and moderately attenuated type II DGK δ and κ.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053090833

Download citation: RISBibTeXText

PMID: 23949095

DOI: 10.1159/000351849


Related references

Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes. Biochemical Pharmacology 59(7): 763-772, 2000

Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. Febs Letters 255(2): 409-413, 1989

The role of diacylglycerol in the exocytosis of the sperm acrosome. Studies using diacylglycerol lipase and diacylglycerol kinase inhibitors and exogenous diacylglycerols. Biochemical Journal 281: 767-773, 1992

Diacylglycerol kinase inhibitors R59022 and dioctanoylethylene glycol potentiate the respiratory burst of neutrophils by raising cytosolic Ca2+. Biochemical and Biophysical Research Communications 161(1): 95-100, 1989

Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase. Journal of Biological Chemistry 280(25): 24238-24244, 2005

Signaling cascade of diacylglycerol kinase β in the pituitary intermediate lobe: dopamine D2 receptor/phospholipase Cβ4/diacylglycerol kinase β/protein kinase Cα. Journal of Histochemistry and Cytochemistry 58(2): 119-129, 2013

Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: Effects of diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid. Biochemical Journal 290(3): 849-856, 1993

Inhibition of thrombin-induced Ca²⁺ influx in platelets by R59949, an inhibitor of diacylglycerol kinase. Journal of Pharmacy and Pharmacology 64(6): 855-861, 2012

The actions of inhibitors of diacylglycerol kinase and diacylglycerol lipase on histamine release from rat peritoneal mast cells. British Journal of Pharmacology 92(3): 597-602, 1987

Neutrophil chemotaxis induced by the diacylglycerol kinase inhibitor R59022. Biochimica Et Biophysica Acta. 1178(1): 97-102, 1993

Induction of neutrophil chemotaxis by the diacylglycerol kinase inhibitor R59022. European Journal of Haematology 51(5): 334, 1993

Diacylglycerol kinase inhibitor R59022 and stimulated neutrophil responses. American Journal of Physiology 255(5 PART 1): C589-C594, 1988

Attenuation of sn 1 2 diacylglycerol second messenger by diacylglycerol kinase inhibition by diacylglycerol analogs in vitro and in human platelets. Journal of Biological Chemistry 261(15): 6993-7000, 1986

The diacylglycerol kinase inhibitor R59022 potentiates superoxide production but not secretion induced by fMet-Leu-Phe: effects of leupeptin and the protein kinase C inhibitor H-7. Biochemical and Biophysical Research Communications 148(1): 38-46, 1987

Inhibitors of diacylglycerol lipase and diacylglycerol kinase inhibit carbamylcholine-stimulated responses in guinea pig pancreatic minilobules. Archives of Biochemistry and Biophysics 256(2): 509-514, 1987